These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3806596)

  • 1. Studies on the active molecular species of the H2 receptor antagonists cimetidine and mifentidine.
    Haaksma EE; Rademaker B; Kramer K; Eriks JC; Bast A; Timmerman H
    J Med Chem; 1987 Jan; 30(1):208-11. PubMed ID: 3806596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.
    Poli E; Medici D; Contini GA; Bertaccini G
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):221-5. PubMed ID: 2860879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between pharmacological response and receptor binding with histamine blocking drugs. Irreversible antagonism of three analogues of mifentidine on right atrium and cerebral cortex of the guinea-pig.
    Kramer K; Bast A; Timmerman H
    Agents Actions; 1987 Jun; 21(1-2):41-8. PubMed ID: 2888281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of the interaction of mifentidine with gastric H2-receptors in the conscious dog.
    Pagani F; Zecca M; Giachetti A
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Sep; 336(3):349-51. PubMed ID: 2891046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of mifentidine, a novel H2-receptor antagonist.
    Pagani F; Micheletti R; Brambilla A; Schiavone A; Montagna E; Ciprandi C; Giachetti A
    Arzneimittelforschung; 1985; 35(1A):451-5. PubMed ID: 2859036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of histamine H2-agonists, a new class of positive inotropic drugs.
    Buschauer A; Baumann G
    Agents Actions Suppl; 1991; 33():231-56. PubMed ID: 1828931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-(fluoroethyl)(imidazolylphenyl)formamidines. The issue of the active species of mifentidine.
    Donetti A; Cereda E; Ezhaya A; Micheletti R
    J Med Chem; 1989 May; 32(5):957-61. PubMed ID: 2565401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipole moment in relation to H2 receptor histamine antagonist activity for cimetidine analogues.
    Young RC; Durant GJ; Emmett JC; Ganellin CR; Graham MJ; Mitchell RC; Prain HD; Roantree ML
    J Med Chem; 1986 Jan; 29(1):44-9. PubMed ID: 3941412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of histamine H1- and H2-receptors in guinea-pig left atrial membranes by [3H]-mepyramine and [3H]-tiotidine binding.
    Hattori Y; Endou M; Gando S; Kanno M
    Br J Pharmacol; 1991 Jun; 103(2):1573-9. PubMed ID: 1909203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational requirements for histamine H2-receptor inhibitors: a structure-activity study of phenylene analogues related to cimetidine and tiotidine.
    Hoffman JM; Pietruszkiewicz AM; Habecker CN; Phillips BT; Bolhofer WA; Cragoe EJ; Torchiana ML; Lumma WC; Baldwin JJ
    J Med Chem; 1983 Feb; 26(2):140-4. PubMed ID: 6131129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of H2 receptor agonists in rabbit atria and aorta.
    Tenner TE
    Pharmacology; 1981; 22(4):227-34. PubMed ID: 6455672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    Cavanagh RL; Usakewicz JJ; Buyniski JP
    J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational studies of two histamine H2-receptor antagonistic phenylformamidines: mifentidine and its guanidinothiazole analogue DA 4643.
    Donetti A; Trummlitz G; Bietti G; Cereda E; Bazzano C; Wagner HU
    Arzneimittelforschung; 1985; 35(1A):306-15. PubMed ID: 2859031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of impromidine (SK&F 92676) on the isolated papillary muscle of the guinea-pig.
    Bertaccini G; Coruzzi G
    Br J Pharmacol; 1981 Feb; 72(2):197-9. PubMed ID: 6452187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the histamine-stimulated adenylate cyclase activity of guinea pig gastric cells by the H2-receptor antagonists cimetidine, oxmetidine and SKF 93479.
    Cheret AM; Scarpignato C; Lewin MJ; Bertaccini G
    Pharmacology; 1984; 28(5):268-74. PubMed ID: 6728900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the new H2-receptor antagonist mifentidine on gastric secretion, gastric emptying and experimental gastric and duodenal ulcers in the rat: comparison with cimetidine and ranitidine.
    Scarpignato C; Tangwa M; Tramacere R; Del Soldato P
    Digestion; 1986; 33(1):7-16. PubMed ID: 2866139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of alpha-adrenergic imidazolines with cardiac histamine H2-receptors.
    Zavecz JH; Yellin TO
    Eur J Pharmacol; 1981 May; 71(2-3):297-306. PubMed ID: 6166486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P; Ghiorzi A; Cereda E; Donetti A
    Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the new H2-receptor antagonist mifentidine on gastric acid secretion in the cat: comparison with cimetidine and ranitidine.
    Scarpignato C; Tramacere R; Tangwa M; Bertaccini G
    Arch Int Pharmacodyn Ther; 1985 Jul; 276(1):142-51. PubMed ID: 2864903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
    Buschauer A
    J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.